Longeveron Inc.
USD0.80
+0.04 (+5.26%)
CEO
Stephen H. Willard
IPO Date
2021-02-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.77
Prev. Close
$0.76
Day Low
$0.76
Day High
$0.83
52W Low
$0.47
52W High
$1.80
Market Cap
$0.02B
Volume
0.33M
| 500,000 |
| $0.00 |
| 5 May 2026 | Blass Devin | CTO & SVP of CMC | A-Award | Acquired | 250,000 | $0.00 |
| 5 May 2026 | Agafonova Nataliya | Chief Medical Officer | A-Award | Acquired | 250,000 | $0.00 |
| 5 May 2026 | Locklear Lisa | Chief Financial Officer | A-Award | Acquired | 250,000 | $0.00 |
| 3 Apr 2026 | Lehr Paul T | General Counsel, Secretary | F-InKind | Disposed | 5,611 | $1.12 |
| 3 Apr 2026 | Agafonova Nataliya | Chief Medical Officer | F-InKind | Disposed | 13,145 | $1.12 |
| 3 Apr 2026 | Locklear Lisa | Chief Financial Officer | F-InKind | Disposed | 13,145 | $1.12 |
| 3 Apr 2026 | Willard Stephen H | Chief Executive Officer | F-InKind | Disposed | 4,740 | $1.12 |
| 3 Apr 2026 | Blass Devin | CTO & SVP of CMC | F-InKind | Disposed | 8,633 | $1.12 |